Restatement of Previously Issued Consolidated Financial Statements (Schedule Of Effects Of Restatement On The Controlling And Noncontrolling Stockholders' Equity) (Details) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023
Noncontrolling Interest [Line Items]
Net loss	$ (7,139)	$ (13,001)	$ (13,403)	$ (4,465)	$ (2,861)	$ (11,324)	$ (33,543)	$ (18,650)
Balance	1,029	6,066	17,728	42,055	47,566	50,972	1,029	42,055
Retained Earnings (Accumulated Deficit) [Member]
Noncontrolling Interest [Line Items]
Net loss	(7,028)	(12,806)	(13,228)	(4,400)	(2,778)	(11,111)
Balance	(112,551)	$ (105,523)	$ (92,717)	$ (67,105)	$ (62,705)	$ (59,927)	(112,551)	$ (67,105)
Previously Reported [Member]
Noncontrolling Interest [Line Items]
Net loss	(7,027)						(29,966)
Balance	4,606						4,606
Previously Reported [Member] | Retained Earnings (Accumulated Deficit) [Member]
Noncontrolling Interest [Line Items]
Balance	(108,974)						(108,974)
Revision of Prior Period, Adjustment [Member]
Noncontrolling Interest [Line Items]
Net loss	(112)						(3,577)
Balance	(3,577)						(3,577)
Revision of Prior Period, Adjustment [Member] | Retained Earnings (Accumulated Deficit) [Member]
Noncontrolling Interest [Line Items]
Balance	$ (3,577)						$ (3,577)